Powered by

Takeda receives shareholders' approval to acquire Shire

Dec 05, 2018 - Marketline Newswire

Takeda Pharmaceutical has secured shareholder approval for the issuance of its shares necessary to implement the proposed $62bn acquisition of Shire.

The Japanese pharmaceutical company received at least 88% of votes exercised in favour of the proposal. Further, at least 87% of the votes exercised were in support of the company's proposal to appoint three of Shire's existing external directors to its board.Takeda Pharmaceutical president and CEO Christophe Weber said: "With sharehold...